CAI · Caris Life Sciences, Inc. · Earnings Calls, Transcripts & Webcasts
$17.58
-0.96 (-5.18%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$5.04B
Shares
286.78M
Volume · Nov 20
4.57M
Avg daily vol (3M)
4.64M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Caris Life Sciences, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Caris Life Sciences, Inc. (CAI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-04
Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call Transcript
Confident tone
Monitoring and MRD launches
Early-stage detection rollout
Clinical evidence and digital AI platform
Revenue
$275.36M
▲ 27% YoY Diluted EPS
$0.05
▼ 37.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-05
Caris Life Sciences, Inc. (CAI) Q2 2026 Earnings Call Transcript
Confident tone
Record clinical volume and case growth
Reimbursement and coverage
Financial performance and profitability
Revenue
$263.71M
▲ 45.4% YoY Diluted EPS
$0.00
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Caris Life Sciences, Inc. (CAI) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-12
Caris Life Sciences, Inc. (CAI) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Caris Life Sciences, Inc. (CAI) Q1 2026 Earnings Call Transcript
Confident tone
MRD pipeline
Profitability and cash generation
New product launches
Revenue
$216.17M
▲ 78.8% YoY Diluted EPS
$0.00
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call Transcript
Confident tone
Profitability and cash flow
Guidance and investment pacing
Commercial expansion
Revenue
$292.89M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Caris Life Sciences, Inc. (CAI) Q3 2025 Earnings Call Transcript
Confident tone
Whole Exome and Whole Transcriptome platform
MRD and monitoring pipeline
Revenue growth and case volumes
Revenue
$216.83M
▲ 113.4% YoY Diluted EPS
$0.08
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Caris Life Sciences, Inc. (CAI) Q2 2025 Earnings Call
Revenue
$181.40M
▲ 81.3% YoY Diluted EPS
$-7.97
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–8 of 8 webcasts
Key facts
CIK
2019410
CUSIP
142152107
13F (30d)
312 filings
296 filers
Visit website
Investor relations